Litcius/Paper detail

Carbonic anhydrase modulation of emotional memory. Implications for the treatment of cognitive disorders

Patrizio Blandina, Gustavo Provensi, Maria Beatrice Passani, Clemente Capasso, Claudiu T. Supuran

2020Journal of Enzyme Inhibition and Medicinal Chemistry74 citationsDOIOpen Access PDF

Abstract

as substrate, catalysing its interconversion to bicarbonate and a proton. In humans 15 CAs are expressed, 12 of which are catalytically active: the cytosolic CA I-III, VII, XIII, the membrane-bound CA IV, the mitochondrial CA VA and VB, the secreted CA VI, and the transmembrane CA IX, XII, XIV. Nine isoforms are present in the mammalian brain. Evidence supporting that CA inhibitors impair memory in humans has come from studies on topiramate and acetazolamide during acute high-altitude exposure. In contrast, administration of CA activators in animal models enhances memory and learning. Here we review the involvement of selective CA inhibition/activation in cognition-related disorders. CAs may represent a crucial family of new targets for improving cognition as well as in therapeutic areas, such as phobias, obsessive-compulsive disorder, generalised anxiety, and post-traumatic stress disorders, for which few efficient therapies are available.

Topics & Concepts

Carbonic anhydraseAnxietyCognitionMonoamine oxidaseChemistryAcetazolamideCarbonic anhydrase inhibitorNeurosciencePsychologyPharmacologyBiochemistryEnzymeInternal medicineMedicinePsychiatryEnzyme function and inhibitionCholinesterase and Neurodegenerative DiseasesSynthesis and Catalytic Reactions